A novel treatment against Atopic Dermatitis
This new treatment has the potential of helping millions globally suffering from unresolved AD.
IVAs 100-lista 2022
We have discovered a novel mechanism of action to suppress itch by inhibiting the release and/or expression of key inflammatory mediators in atopic dermatitis (AD) using oligonucleotides, i.e. induction of immune regulation.
We have formulated a water-soluble topical cream, TIR-C, containing therapeutic molecules that stimulate immunomodulatory effects without leading to systemic toxicity. This new treatment has the potential of helping millions globally suffering from unresolved AD.
